Stockscreener 앱 받기
2.58
6.86%
-0.19
시간 외 거래:
2.59
0.010
+0.39%
Codexis Inc 주식(CDXS)의 최신 뉴스
Synthetic Biology Market Key Players AnalysisBota - openPR.com
Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World
Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World
Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis at Jefferies Global Healthcare Conference: Enzymatic Synthesis Insights By Investing.com - Investing.com Canada
ProShare Advisors LLC Has $127,000 Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Deutsche Bank AG Raises Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $218,000 Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Opaleye Management Makes a Bold Move with Massive Codexis Stock Purchase - TipRanks
Group One Trading LLC Buys Shares of 15,226 Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Stake Lifted by Northern Trust Corp - Defense World
Codexis’ Landmark Presentations at TIDES USA Highlight - GlobeNewswire
Transcript : Codexis, Inc.Special Call - marketscreener.com
Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at T - GuruFocus
Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at TIDES USA | CDXS Stock News - GuruFocus
Codexis Highlights Advancements in Eco Synthesis Technology for siRNA Manufacturing at TIDES USA Conference - Nasdaq
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process ... - Bluefield Daily Telegraph
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire Inc.
Codexis to Participate in Jefferies Global Healthcare Conference - The Manila Times
Codexis to Participate in Jefferies Global Healthcare Conference | CDXS Stock News - GuruFocus
Argan Strengthens Board with Energy Giant Sempra Executive: Strategic Growth Move - Stock Titan
Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth - Investing.com Australia
Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth By Investing.com - Investing.com Canada
Former Genentech and Codexis Legal Leader Takes Top Legal Role at Liver Disease Biotech Aligos - Stock Titan
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by Ameriprise Financial Inc. - Defense World
Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World
Codexis (NASDAQ:CDXS) Stock Rating Upgraded by StockNews.com - Defense World
Price T Rowe Associates Inc. MD Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call Transcript - Insider Monkey
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial Corp - Defense World
Codexis Earnings Call: Strategic Growth Amid Challenges - TipRanks
Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - MSN
Stifel maintains Buy rating on Codexis stock with $5 target By Investing.com - Investing.com India
Stifel maintains Buy rating on Codexis stock with $5 target - Investing.com
Codexis May 2025 presentation slides: RNA manufacturing pivot targets path to profitability - Investing.com Canada
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with Strategic Growth Initiatives - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings: EPS at -$0.23 and Revenue H - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... - Yahoo Finance
Codexis Reports Q1 2025 Financial Results and Strategic Progress - TipRanks
Codexis: Q1 Earnings Snapshot - MySA
Earnings call transcript: Codexis Q1 2025 results miss forecasts, stock declines - Investing.com Nigeria
Codexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 Ou - GuruFocus
1.08%
2.14%
자본화:
|
볼륨(24시간):